Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$1.74 - $3.6 $342 - $709
-197 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$3.18 - $5.17 $10,503 - $17,076
-3,303 Reduced 94.37%
197 $1,000
Q2 2021

Aug 16, 2021

BUY
$3.53 - $6.1 $12,355 - $21,350
3,500 New
3,500 $19,000

Others Institutions Holding GRAY

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About GRAYBUG VISION, INC.


  • Ticker GRAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,517,700
  • Market Cap $63.5M
  • Description
  • Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the t...
More about GRAY
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.